According to the report “Drugs for the Diseases of Ageing” in 2010, sales of ageing drugs used solely by people aged 50+ hit $50 billion. To 2015, sales will grow 5.3% annually to reach over $64 billion.
On a segment by segment basis, medicines used for wrinkle reduction will exhibit the greatest growth at 17.7% per year, followed by drugs used to address Alzheimer’s disease at 12.1% per year.
This report gathers historical information from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources.
The 263 page study also provides interviews with company representatives to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.
Market segments examined include:
- Alzheimer’s disease
- Arthritis
- Cancer
- Cardiovascular disease
- Diabetes
- Erectile dysfunction
- Eye disease
- Hair loss
- High cholesterol
- Hypertension
- Kidney disease
- Osteoporosis
- Parkinson’s disease
- Stroke
- Wrinkles
The report “Drugs for the Diseases of Aging”
